|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:E590100 |
| 產(chǎn)品名稱:Eprosartan |
| 產(chǎn)品CAS:133040-01-4 |
| 規(guī)格含量:25mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
E590100 |
| 名稱: |
Eprosartan |
| 別名: |
(αE)-α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (E)-2-Butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic Acid; Navixen; SKB 108566; SKF 108566; Teveten; |
| CAS號: |
133040-01-4 |
| 分子式: |
C??H??N?O?S |
| 外觀: |
淡黃色固體 |
| 熔點(diǎn): |
>246°C (dec.) |
| 分子量: |
424.51 |
| 儲(chǔ)存: |
-20°C Freezer |
| 溶解度: |
Methanol |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| Boiling Point: |
N/A |
| 應(yīng)用: |
Eprosartan is a prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Eprosartan is an antihypertensive. |
| 參考文獻(xiàn) |
|
|
|
|
|
|